Inogen | INGN - Capital Social e Reservas





Capital Social e Reservas Alterar Data
Abbott USD 52.06B 69M 2026-03
Accuray USD 53.42M 8.45M 2025-12
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 445.58M 4.88M 2026-06
AtriCure USD 516.43M 24.74M 2026-06
Baxter International USD 6.21B 163M 2026-06
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Boston Scientific USD 24.93B 934M 2026-06
Cooper Companies USD 8.33B 89.1M 2026-06
Dexcom USD 2.62B 335.5M 2026-06
Edwards Lifesciences USD 10.62B 290.5M 2026-06
Globus Medical USD 4.77B 36.29M 2026-06
Inogen USD 197.18M 2.32M 2025-09
Insulet USD 1.42B 119.6M 2026-06
Medtronic USD 50.23B 160M 2026-06
Orthofix International USD 429.18M 6.01M 2026-06
Philips EUR 11.48B 84M 2026-06
ResMed USD 6.59B 93.48M 2026-06
Steris USD 7.21B 23.1M 2026-06
Stryker USD 22.98B 559M 2026-03
Tandem Diabetes Care USD 130.39M 2.02M 2026-06
Teleflex USD 2.9B 179.9M 2026-06
X T L Biopharmaceuticals USD -254K 207K 2025-12
Zimmer Biomet Holdings USD 12.63B 49.1M 2026-06